Does INSULIN ASPART Cause Neoplasm malignant? 107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Neoplasm malignant have been filed in association with INSULIN ASPART (NovoLog Mix 70/30). This represents 0.5% of all adverse event reports for INSULIN ASPART.
107
Reports of Neoplasm malignant with INSULIN ASPART
0.5%
of all INSULIN ASPART reports
16
Deaths
23
Hospitalizations
How Dangerous Is Neoplasm malignant From INSULIN ASPART?
Of the 107 reports, 16 (15.0%) resulted in death, 23 (21.5%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN ASPART. However, 107 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN ASPART Cause?
Blood glucose increased (4,743)
Hypoglycaemia (1,647)
Blood glucose decreased (1,421)
Diabetic ketoacidosis (1,398)
Drug ineffective (1,243)
Product quality issue (1,049)
Dyspnoea (746)
Vomiting (727)
Malaise (706)
Nausea (694)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which INSULIN ASPART Alternatives Have Lower Neoplasm malignant Risk?
INSULIN ASPART vs INSULIN ASPART\INSULIN DEGLUDEC
INSULIN ASPART vs INSULIN BEEF
INSULIN ASPART vs INSULIN DEGLUDEC
INSULIN ASPART vs INSULIN DEGLUDEC\LIRAGLUTIDE
INSULIN ASPART vs INSULIN DETEMIR